Fanvue | $22,000,000 | (Jan 20, 2026)
Dominion Dynamics | $15,200,000 | (Jan 20, 2026)
Tulip Interfaces | $120,000,000 | (Jan 20, 2026)
Certified by Founder
Lodge
Dispatch Bio
start up
- 24/07/2025
- Series A
- Undisclosed Amount
Established in 2022, Dispatch Bio was founded with a bold purpose: to help create a world where all cancer patients can be cured. To achieve this, the company is engineering a universal treatment across solid tumors, leveraging its first-in-class Flare platform. This novel approach combines the strengths of immunotherapy with a tumor-specific viral vector, both engineered to clear tumor cells with precision and power. Dispatch has operations in Philadelphia and San Francisco, with access to world-class researchers.
- Industry Biotechnology Research
- Website https://dispatchbio.com/
- LinkedIn https://www.linkedin.com/company/dispatch-bio/
Fleetzero | $43,000,000 | (Jan 20, 2026)
EXCIVA GmbH | $59,817,135 | (Jan 20, 2026)
Transition Metal Solutions | $6,000,000 | (Jan 20, 2026)
one • fıve | $16,320,500 | (Jan 20, 2026)
Anzen Industries | $2,283,975 | (Jan 20, 2026)
Gutology | $2,418,300 | (Jan 20, 2026)
GovDash | $30,000,000 | (Jan 16, 2026)
RouteSense | $2,000,000 | (Jan 16, 2026)
Vista AI | $29,500,000 | (Jan 16, 2026)